Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals
  • Primary Care

    Supporting every aspect of your clinical practice, including physical exam, diagnostic cardiology, vitals monitoring and vision screening

  • Hospital Care

    Advancing products and technologies designed to speed patient recovery and streamline clinical workflows

  • Surgical Care

    Delivering innovations that enable reduced operating times, faster patient recovery and improved outcomes

  • Nutritional Care

    Personalizing nutritional care designed to improve patients’ health in the hospital, the ICU and at home

  • Respiratory Care

    Helping your patients with respiratory therapies designed to simplify delivery and improve mobility

  • Our Products & Services

    Our portfolio of acute, nutritional, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For nearly a century, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our 90-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Leadership

    Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere.

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We strive to create lasting value by empowering our patients, protecting our planet and championing our people and communities.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For nearly a century, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • General Healthcare

    Whether you are receiving care in the hospital, at your doctor’s office or at home, we are here to support every step of your journey.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain your nutritional status.

  • Respiratory Care

    We are committed to helping you with innovative products that deliver effective, proven respiratory therapy in the hospital and at home.

Search Results

Baxter to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 10:35 a.m. Eastern Time.   The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through March 13, 2023.

Collage of profile images of BRG leaders

Different Abilities, Unlimited Potential

Baxter cultivates inclusive culture for individuals with disabilities  

Employees and humanitarian organizations deliver donated products

Working Together to Support Patient Care in Ukraine

Baxter employees from multiple countries and departments partner with humanitarian aid organizations to help support impacted communities    

Semiconductor Chip Shortage is Impacting Patient Care Globally

Baxter International Inc. (NYSE:BAX), a global medtech leader, and its suppliers have been impacted by shortages of electromechanical components, including semiconductor chips, used in many of its products. Several of the company's critical products require multiple chips per device, including infusion pumps, patient monitoring systems and continuous renal replacement therapy systems.

Baxter Issues Urgent Medical Device Recall of Clearlink Solution Set 2R8403 Due to Potential Risk of Leaking Complications

Baxter International Inc. announced today it has issued an Urgent Medical Device Recall of Clearlink Solution Set 2R8403 due to an increase in customer reports of leaks. The affected product was distributed to customers beginning on Oct. 14, 2020, in the United States.

A patient smiles outside a hotel resort

Hope Starts at Home

Dawn is a mom and travel and shopping enthusiast. But her true passion lies in being a full-time kidney patient advocate who regularly speaks to patients about her 30-year care journey. She aims to empower others to take an active role with their healthcare team in making therapy choices, including starting on home dialysis when possible.      

Baxter Reports Second-Quarter 2022 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2022.

Collage of Baxter Women Leaders

Leading the Way

Baxter continues to excel in cultivating women leaders

Baxter Issues Urgent Medical Device Correction Regarding Potential Risk of Medication Error When Using Abacus Order Entry and Calculation Software

Baxter International Inc. announced today it has issued an Urgent Medical Device Correction regarding the potential risk of medication error when using certain product codes for the Abacus Order Entry and Calculation Software. The Abacus software is commonly used with ExactaMix automated compounding devices (ExactaMix 1200 and ExactaMix 2400).

Financial Content

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on October 3, 2022, to shareholders of record as of September 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock.